Consolidated Statement of Operations - USD ($)	3 Months Ended		9 Months Ended
	Jul. 31, 2021	Jul. 31, 2020	Jul. 31, 2021	Jul. 31, 2020
Details
Revenues	$ 1,509,808	$ 2,207,722	$ 4,669,573	$ 9,611,780
Cost of expenses:
Cost of revenues	579,491	860,540	1,714,615	5,567,720
Research and development expenses	55,802	66,042	156,685	281,739
Selling, general, and administrative expenses	672,399	1,272,376	1,987,183	5,733,142
Operating Expenses	1,307,692	2,198,958	3,858,483	21,456,882
Impairment charges			0	9,874,281
Income/(Loss) from operations	202,116	8,764	811,090	(11,845,102)
Interest expense - related party	266,400	238,826	790,513	667,741
Other loss	0	19,473	0	19,473
Income/(Loss) before income taxes	(64,284)	(249,535)	20,577	(12,532,316)
Provision for income taxes	0	0	0	31,560
Net Income/(Loss)	$ (64,284)	$ (249,535)	$ 20,577	$ (12,563,876)
Net income/(loss) per common share - basic	$ (0.01)	$ (0.03)	$ 0.00	$ (1.63)
Net income/(loss) per common share - diluted	$ (0.01)	$ (0.03)	$ 0.00	$ (1.63)
Weighted average number of common shares outstanding - basic	7,712,091	7,712,091	7,712,091	7,710,047
Weighted average number of common shares outstanding - diluted	7,712,091	7,712,091	7,748,451	7,710,047